Amalgamated Bank 9 Meters Biopharma, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $9,583 - $23,591	-36,861 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.52 - $1.0 $1,501 - $2,888	-2,888 Reduced 7.27%	36,861 $22,000
Q4 2021 Feb 15, 2022	SELL	$0.85 - $1.33 $595 - $932	-701 Reduced 1.73%	39,749 $39,000
Q3 2021 Oct 29, 2021	BUY	$1.03 - $1.41 $326 - $446	317 Added 0.79%	40,450 $53,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $41,738 - $60,199	40,133 New	40,133 $44,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.